Pertussis vaccine

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates
Name
Pertussis vaccine
Accession Number
DB15274
Type
Biotech
Groups
Approved, Investigational
Description

Pertussis vaccine is under investigation in clinical trial NCT01698346 (Pertussis (Tdap) Vaccination in Pregnancy).

Synonyms
  • Bordetella pertussis
Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Pertussis Vaccine 4 Protect UnitSuspensionSubcutaneousAventis Pasteur Limited1921-12-312001-07-19Canada
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
Diphtheria and Tetanus Toxoids With Pertussis Vaccine AdsorbedPertussis vaccine (12 unit) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 lf) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (25 lf)LiquidIntramuscularAventis Pasteur Limited1980-12-312001-07-19Canada
Tri-immunol Liq ImPertussis vaccine (4 unit) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 lf) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (12.5 lf)LiquidIntramuscularLederle Labs, Division of American Cyanamid Co1993-12-312001-06-05Canada
Categories
UNII
2QNL82089R
CAS number
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
2-MethoxyethanolThe therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with 2-Methoxyethanol.
9-(N-methyl-L-isoleucine)-cyclosporin AThe therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with 9-(N-methyl-L-isoleucine)-cyclosporin A.
AbataceptThe therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Abatacept.
AbetimusThe therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Abetimus.
ActeosideThe therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Acteoside.
AdalimumabThe therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Adalimumab.
AfelimomabThe therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Afelimomab.
AlclometasoneThe therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Alclometasone.
AldesleukinThe therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Aldesleukin.
AldosteroneThe therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Aldosterone.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
Not Available
External Links
Wikipedia
Pertussis_vaccine

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedBasic ScienceHealthy Volunteers1
1CompletedPreventionDiphtheria / Lockjaw / Pertussis / Tetanus / Whooping Cough1
1CompletedPreventionDiphtheria / Pertussis / Tetanus2
1CompletedPreventionInfections, Pneumococcal1
1CompletedPreventionWhooping Cough1
1CompletedTreatmentHuman Immunodeficiency Virus (HIV) Infections1
1Not Yet RecruitingPreventionDiphtheria / Pertussis / Tetanus1
1, 2CompletedPreventionDiphtheria / Pertussis / Tetanus / Whooping Cough1
1, 2RecruitingPreventionWhooping Cough1
2Active Not RecruitingPreventionClostridium Difficile Immunisation / Diphtheria / Diphtheria Immunisation / Pertussis / Tetanus / Tetanus Immunisation1
2Active Not RecruitingTreatmentChronic Lymphocytic Leukaemia (CLL) / Small Lymphocytic Lymphoma1
2CompletedPreventionDengue Fever / Dengue Hemorrhagic Fever1
2CompletedPreventionDiphtheria / Pertussis / Poliomyelitis / Tetanus / Viral Hepatitis B1
2CompletedPreventionMeningitis / Meningococcal Infections / Meningococcal Meningitis1
2Enrolling by InvitationPreventionPertussis / Whooping Cough1
3Active Not RecruitingPreventionDengue Fever / Dengue Hemorrhagic Fever1
3CompletedPreventionAcellular Pertussis / Diphtheria / Pertussis / Poliomyelitis / Prophylaxis / Tetanus1
3CompletedPreventionAcellular Pertussis / Diphtheria / Pertussis / Tetanus1
3CompletedPreventionDiphteria, Tetanus and Pertussis1
3CompletedPreventionDiphtheria / Haemophilus Influenzae Type B / Pertussis / Poliomyelitis / Tetanus2
3CompletedPreventionDiphtheria / Haemophilus Influenzae Type B / Poliomyelitis / Tetanus / Whooping Cough1
3CompletedPreventionDiphtheria / Pertussis / Tetanus5
3CompletedPreventionHealthy Volunteers1
3CompletedPreventionHealthy Volunteers / Infants1
3CompletedPreventionMeningitis / Meningococcal Disease1
3CompletedPreventionMeningococcal Disease / Meningococcal Meningitis1
3CompletedPreventionMeningococcal Meningitis1
3CompletedPreventionPertussis2
4Active Not RecruitingPreventionDiphtheria / Pertussis / Tetanus1
4CompletedPreventionDiphtheria / Pertussis / Tetanus / Whooping Cough2
4CompletedPreventionFebrile Convulsions / Fever After Vaccination / Fevers1
4CompletedPreventionHealthy Volunteers1
4CompletedPreventionInfluenza, Human1
4CompletedPreventionMeningococcal Meningitis1
4CompletedPreventionPertussis / Pregnancy1
4CompletedPreventionPregnancy1
4RecruitingPreventionApnea / Apnoea neonatal / Infants, Premature1
4Unknown StatusPreventionRheumatoid Arthritis1
Not AvailableCompletedNot AvailableDiphtheria1
Not AvailableCompletedPreventionHuman Immunodeficiency Virus (HIV) Infections / Infections, Pneumococcal / Pertussis / Rubeola / Viral Hepatitis B1
Not AvailableRecruitingBasic ScienceHeterologous Effects of Vaccines1
Not AvailableRecruitingOtherWhooping Cough1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
LiquidIntramuscular
SuspensionSubcutaneous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on May 20, 2019 09:06 / Updated on February 02, 2020 03:22